Search
You have searched for "Single-Dose Vaccine"
Showing 51-59 of 59
Malaysia may add Johnson & Johnson to its vaccine armoury
PUTRAJAYA: Malaysia looks set to add Johnson & Johnson to its lineup of Covid-19 vaccine suppliers, in a boost to the country’s National Covid-19 Immunisation Programme.
Undocumented migrants will not be detained when they come for Covid-19 vaccinations, says Khairy
PUTRAJAYA: Undocumented migrants in Malaysia have been given assurance that they will not be detained if they come for Covid-19 vaccinations.
J&J vaccine adds to COVID-19 armoury, includes South African variant
(Reuters) - Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health officials another weapon to tackle the pandemic.
Instant View: J&J COVID-19 vaccine is 66% effective globally
(Reuters) - Johnson & Johnson said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States but a lower rate of 66% was observed globally in the large trial conducted across three continents and against multiple variants.
Exclusive: Chile could greenlight AstraZeneca vaccine 'within days of US/UK approval, government says
SANTIAGO (Reuters) - AstraZeneca has filed data with Chilean regulators for the emergency roll-out of its COVID-19 vaccine in the country and could get a green light "weeks or even days" after approval by European or American regulators, the government's point person for vaccine procurement told Reuters.
J&J enrolls about 45,000 participants for late-stage COVID-19 vaccine trial
(Reuters) -Johnson & Johnson said on Thursday it has enrolled about 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate and that it expects interim data by late-January.
J&J expects data for U.S. authorization of COVID-19 vaccine by Feb, says head scientist
(Reuters) - Johnson & Johnson's
Roundup: Fourth large-scale COVID-19 vaccine trial starts in U.S.
WASHINGTON, Sept. 23 (Xinhua) -- A fourth Phase 3 clinical trial evaluating an investigational COVID-19 vaccine has begun enrolling adult volunteers, the U.S. National Institutes of Health (NIH) announced on Wednesday.
Congo's Ebola outbreak slows but still entrenched in insecure areas - WHO
GENEVA (Reuters) - The Ebola epidemic in northeastern Democratic Republic of Congo has been confined to a rural area rife with militias and people on the move, making it harder to stamp out altogether, the World Health Organization (WHO) said on Thursday.
